Abstract
ObjectiveTo determine the risk of dementia after the development of late-onset epilepsy.MethodsWe used data from the Atherosclerosis Risk in Communities (ARIC) cohort study, which started in 1987 to 1989 with 15,792 mostly Black and White men and women from 4 US communities. We identified late-onset epilepsy (LOE; seizures starting at age 67 or later) from linked Medicare claims data. We used a Cox proportional hazards regression model to evaluate associations between LOE and dementia through 2017 as ascertained from neuropsychological testing, interviews, and hospital discharge surveillance, and we used multinomial logistic regression to assess the risk of dementia and mild cognitive impairment in the subset with full neuropsychological assessments available. We adjusted for demographics and vascular and Alzheimer disease risk factors.ResultsOf 9,033 ARIC participants with sufficient Medicare coverage data (4,980 [55.1%] female, 1993 [22.1%] Black), 671 met the definition of LOE. Two hundred seventy-nine (41.6%) participants with and 1,408 (16.8%) without LOE developed dementia (p < 0.001). After a diagnosis of LOE, the adjusted hazard ratio for developing subsequent dementia was 3.05 (95% confidence interval 2.65-3.51). The median time to dementia ascertainment after the onset of LOE was 3.66 years (quartile 1-3, 1.28-8.28 years).InterpretationThe risk of incident dementia is substantially elevated in individuals with LOE. Further work is needed to explore causes for the increased risk of dementia in this growing population.
| Original language | English |
|---|---|
| Pages (from-to) | E3248-E3256 |
| Journal | Neurology |
| Volume | 95 |
| Issue number | 24 |
| DOIs | |
| State | Published - Dec 15 2020 |
Bibliographical note
Publisher Copyright:© American Academy of Neurology.
Funding
The ARIC study has been funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, NIH, Department of Health and Human Services, under contracts HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, and HHSN268201700005I. Neurocognitive data are obtained by grants U01 HL096812, U01 HL096814, U01 HL096899, U01 HL096902, and U01 HL096917 from the National Heart, Lung, and Blood Institute, with funding also provided by the National Institute of Neurological Disorders and Stroke. This study was also supported by contract K24 AG052573 (Dr. Gottesman) from the National Institute on Aging.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| U.S. Department of Health and Human Services | U01 HL096814, U01 HL096902, U01 HL096899, U01 HL096812, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I, U01 HL096917, HHSN268201700001I, HHSN268201700002I |
| U.S. Department of Health and Human Services | |
| National Institute on Aging | |
| National Heart, Lung, and Blood Institute Family Blood Pressure Program | U01HL096814 |
| National Heart, Lung, and Blood Institute Family Blood Pressure Program | |
| Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council | K24 AG052573 |
| Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council |
ASJC Scopus subject areas
- Clinical Neurology